Abviva, Inc. Announces Investor Conference Call and Webcast
Genesis Bioventures zu myNews hinzufügen Was ist das?
Abviva, Inc. (f/k/a Genesis Bioventures, Inc. OTCBB:GBIW) today
announced that it has scheduled an investor conference call and webcast
to take place on Monday, December 10, 2007 at 4:00 p.m. U.S. EST . Mr.
Douglas C. Lane, President and CEO, will discuss with investors the
Company’s progress and third quarter
performance.
December 10, 2007 Schedule
4:00 p.m. EST
To participate in the conference call,dial 1-(641)-715-3222
and refer toConference Access Code Number 426-438-867;
4:00 p.m. EST
Conference call begins promptly at 4:00 pm.
September 10, 2007 Simultaneous Webcast
The public may access a live webcast on the conference call by
registering for the webcast at https://www1.gotomeeting.com/register/514659630
and completing the registration information form. To listen to the audio
portion of the webcast participants need to dial in to the conference
call number, 1-(641)-715-3222, and refer to Conference Access Code
Number 426-438-867.
About Abviva, Inc.
Abviva, Inc. is a biomedical company focused on the commercialization of
its owned and licensed assets for breast cancer diagnostics and for
breast cancer therapeutic development.
Statements in this press release that are not strictly historical
facts are "forward-looking" statements (identified by the words
"believe", "estimate", "project", "expect" or similar expressions)
within the meaning of the Private Securities Litigation Reform Act of
1995. These statements inherently involve risks and uncertainties that
could cause actual results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such differences
include, but are not limited to, continued acceptance of the Company's
products and services in the marketplace, competitive factors, changes
in the regulatory environment, and other risks detailed in the Company's
periodic report filings with the Securities and Exchange Commission. The
statements in this press release are made as of today, based upon
information currently known to management, and the Company does not
undertake any obligation to publicly update or revise any
forward-looking statements.
